Home Other Building Blocks 4294-16-0
4294-16-0,MFCD00005740
Catalog No.:AA00BXHQ

4294-16-0 | N6-BENZYLADENOSINE

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
98%
in stock  
$50.00   $35.00
- +
1g
98%
in stock  
$70.00   $49.00
- +
5g
98%
in stock  
$115.00   $81.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00BXHQ
Chemical Name:
N6-BENZYLADENOSINE
CAS Number:
4294-16-0
Molecular Formula:
C17H19N5O4
Molecular Weight:
357.3639
MDL Number:
MFCD00005740
SMILES:
OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NCc1ccccc1
Properties
Computed Properties
 
Complexity:
466  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
4  
Heavy Atom Count:
26  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
4  
Rotatable Bond Count:
5  
XLogP3:
1.1  

Literature

Title: Effects of cytokinins, cytokinin ribosides and their analogs on the viability of normal and neoplastic human cells.

Journal: Anticancer research 20111001

Title: Halogenation of N⁶-benzyladenosine decreases its cytotoxicity in human leukemia cells.

Journal: Toxicology in vitro : an international journal published in association with BIBRA 20101201

Title: N⁶-Alkyladenosines: Synthesis and evaluation of in vitro anticancer activity.

Journal: Bioorganic & medicinal chemistry 20101201

Title: Anticancer activity of natural cytokinins: a structure-activity relationship study.

Journal: Phytochemistry 20100801

Title: Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity.

Journal: The Journal of general virology 20081001

Title: Ribose-modified purine nucleosides as ribonucleotide reductase inhibitors. Synthesis, antitumor activity, and molecular modeling of N6-substituted 3'-C-methyladenosine derivatives.

Journal: Journal of medicinal chemistry 20080724

Title: Probing distal regions of the A2B adenosine receptor by quantitative structure-activity relationship modeling of known and novel agonists.

Journal: Journal of medicinal chemistry 20080410

Title: Constrained NBMPR analogue synthesis, pharmacophore mapping and 3D-QSAR modeling of equilibrative nucleoside transporter 1 (ENT1) inhibitory activity.

Journal: Bioorganic & medicinal chemistry 20080401

Title: Cytokinins in the bryophyte Physcomitrella patens: analyses of activity, distribution, and cytokinin oxidase/dehydrogenase overexpression reveal the role of extracellular cytokinins.

Journal: Plant physiology 20071101

Title: Preparation, biological activity and endogenous occurrence of N6-benzyladenosines.

Journal: Bioorganic & medicinal chemistry 20070601

Title: Synthesis, biological evaluation and molecular modeling studies of N6-benzyladenosine analogues as potential anti-toxoplasma agents.

Journal: Biochemical pharmacology 20070515

Title: Caspase inhibition and N6-benzyladenosine-induced apoptosis in HL-60 cells.

Journal: Journal of cellular biochemistry 20010101

Title: 2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors.

Journal: Journal of medicinal chemistry 19941014

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:4294-16-0 Molecular Formula|4294-16-0 MDL|4294-16-0 SMILES|4294-16-0 N6-BENZYLADENOSINE